US FDA’s Inspection Volume Projected To Return To Normal Levels In FY 2022 As Backlog Looms
Executive Summary
Additional hiring in FDA’s FY 2022 budget request also is expected to help address the inspections delayed by the coronavirus pandemic.
You may also be interested in...
US FDA Strengthens Inspection Capabilities With Pandemic Alternatives – And Travel Savings
Agency’s Office of Regulatory Affairs mines third-country EU inspections and remotely delivered documents while investing travel savings, redirecting field force and preparing for new post-pandemic travel challenges.
Biden Requests US FDA Budget Surge: Pandemic Preparedness Money Would Increase Funding 36%
President Biden’s budget request would add $1.63bn in mandatory funding to the FDA budget in FY 2023.
GAO Advises US FDA On Inspection Pilot Plans; Notes Increased Oversight Of OAI Downgrades
As omicron COVID-19 variant recedes, GAO shares thoughts on FDA’s plans for unannounced foreign inspections and translation services pilots. The report also details agency efforts to fill vacant foreign inspection positions.